CA1113395A - Delivery system - Google Patents

Delivery system

Info

Publication number: CA1113395A
Authority: CA; Canada
Prior art keywords: chemical; reservoir; poly; morantel; sintered
Prior art date: 1978-05-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA327,100A

Other languages

English (en)

French (fr)

Inventor

David S. Dresback

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Ltd Great Britain

Original Assignee

Pfizer Ltd Great Britain

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-05-08

Filing date

1979-05-07

Publication date

1981-12-01

1979-02-22 Priority claimed from US06/014,388 external-priority patent/US4220153A/en

1979-02-22 Priority claimed from US06/014,387 external-priority patent/US4220152A/en

1979-05-07 Application filed by Pfizer Ltd Great Britain filed Critical Pfizer Ltd Great Britain

1981-12-01 Application granted granted Critical

1981-12-01 Publication of CA1113395A publication Critical patent/CA1113395A/en

Status Expired legal-status Critical Current

Links

239000011148 porous material Substances 0.000 claims abstract description 121
239000000126 substance Substances 0.000 claims abstract description 99
239000000017 hydrogel Substances 0.000 claims abstract description 85
239000007788 liquid Substances 0.000 claims abstract description 63
238000000034 method Methods 0.000 claims abstract description 51
241001465754 Metazoa Species 0.000 claims abstract description 48
229920002284 Cellulose triacetate Polymers 0.000 claims abstract description 36
NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 claims abstract description 36
239000000463 material Substances 0.000 claims abstract description 34
241000282849 Ruminantia Species 0.000 claims abstract description 33
239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 27
239000004744 fabric Substances 0.000 claims abstract description 22
230000008569 process Effects 0.000 claims abstract description 16
239000003599 detergent Substances 0.000 claims abstract description 9
-1 poly(ethylene) Polymers 0.000 claims description 66
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 51
229960005121 morantel Drugs 0.000 claims description 45
NVEPPWDVLBMNMB-SNAWJCMRSA-N 1-methyl-2-[(e)-2-(3-methylthiophen-2-yl)ethenyl]-5,6-dihydro-4h-pyrimidine Chemical compound CN1CCCN=C1\C=C\C1=C(C)C=CS1 NVEPPWDVLBMNMB-SNAWJCMRSA-N 0.000 claims description 44
230000002035 prolonged effect Effects 0.000 claims description 28
150000003839 salts Chemical class 0.000 claims description 21
238000009304 pastoral farming Methods 0.000 claims description 19
244000000013 helminth Species 0.000 claims description 16
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 13
HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 claims description 13
229910000831 Steel Inorganic materials 0.000 claims description 13
238000011109 contamination Methods 0.000 claims description 13
229960001614 levamisole Drugs 0.000 claims description 13
239000010959 steel Substances 0.000 claims description 13
229920001155 polypropylene Polymers 0.000 claims description 12
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 9
108010034145 Helminth Proteins Proteins 0.000 claims description 9
239000004698 Polyethylene Substances 0.000 claims description 9
229940124339 anthelmintic agent Drugs 0.000 claims description 9
239000000921 anthelmintic agent Substances 0.000 claims description 9
229920000573 polyethylene Polymers 0.000 claims description 9
229960005134 pyrantel Drugs 0.000 claims description 9
229940095064 tartrate Drugs 0.000 claims description 9
YSAUAVHXTIETRK-AATRIKPKSA-N pyrantel Chemical compound CN1CCCN=C1\C=C\C1=CC=CS1 YSAUAVHXTIETRK-AATRIKPKSA-N 0.000 claims description 8
239000002253 acid Substances 0.000 claims description 6
239000011521 glass Substances 0.000 claims description 6
229910052742 iron Inorganic materials 0.000 claims description 6
LAZPBGZRMVRFKY-HNCPQSOCSA-N Levamisole hydrochloride Chemical compound Cl.C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 LAZPBGZRMVRFKY-HNCPQSOCSA-N 0.000 claims description 5
229920002821 Modacrylic Polymers 0.000 claims description 5
238000007792 addition Methods 0.000 claims description 5
229960003734 levamisole hydrochloride Drugs 0.000 claims description 5
238000004519 manufacturing process Methods 0.000 claims description 5
229920001343 polytetrafluoroethylene Polymers 0.000 claims description 5
239000004793 Polystyrene Substances 0.000 claims description 4
229920000915 polyvinyl chloride Polymers 0.000 claims description 4
239000004800 polyvinyl chloride Substances 0.000 claims description 4
BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 claims description 3
150000001860 citric acid derivatives Chemical class 0.000 claims description 3
229920002223 polystyrene Polymers 0.000 claims description 3
230000002844 continuous effect Effects 0.000 claims description 2
230000006872 improvement Effects 0.000 claims description 2
229920000136 polysorbate Polymers 0.000 claims 1
150000003892 tartrate salts Chemical class 0.000 claims 1
239000003814 drug Substances 0.000 abstract description 140
229940079593 drug Drugs 0.000 abstract description 139
238000013270 controlled release Methods 0.000 abstract description 36
238000002360 preparation method Methods 0.000 abstract description 3
229960003546 morantel tartrate Drugs 0.000 description 23
GGXQONWGCAQGNA-UUSVNAAPSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;1-methyl-2-[(e)-2-(3-methylthiophen-2-yl)ethenyl]-5,6-dihydro-4h-pyrimidine Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.CN1CCCN=C1\C=C\C1=C(C)C=CS1 GGXQONWGCAQGNA-UUSVNAAPSA-N 0.000 description 22
239000000243 solution Substances 0.000 description 22
244000309466 calf Species 0.000 description 18
229940068918 polyethylene glycol 400 Drugs 0.000 description 17
239000010935 stainless steel Substances 0.000 description 16
229910001220 stainless steel Inorganic materials 0.000 description 16
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
239000000203 mixture Substances 0.000 description 15
238000009792 diffusion process Methods 0.000 description 14
241000283690 Bos taurus Species 0.000 description 13
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
229920006217 cellulose acetate butyrate Polymers 0.000 description 11
238000000338 in vitro Methods 0.000 description 11
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 10
239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 10
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
235000013601 eggs Nutrition 0.000 description 9
239000012528 membrane Substances 0.000 description 9
230000035699 permeability Effects 0.000 description 9
GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 9
235000019982 sodium hexametaphosphate Nutrition 0.000 description 9
238000012360 testing method Methods 0.000 description 9
241001494479 Pecora Species 0.000 description 8
229910052751 metal Inorganic materials 0.000 description 8
239000002184 metal Substances 0.000 description 8
229920000642 polymer Polymers 0.000 description 8
229920002451 polyvinyl alcohol Polymers 0.000 description 8
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
239000004372 Polyvinyl alcohol Substances 0.000 description 7
229910052782 aluminium Inorganic materials 0.000 description 7
229920002678 cellulose Polymers 0.000 description 7
230000001418 larval effect Effects 0.000 description 7
239000000700 radioactive tracer Substances 0.000 description 7
OLOCXIJVDIVAHH-FXRZFVDSSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;1-methyl-2-[(e)-2-(3-methylthiophen-2-yl)ethenyl]-5,6-dihydro-4h-pyrimidine Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CN1CCCN=C1\C=C\C1=C(C)C=CS1 OLOCXIJVDIVAHH-FXRZFVDSSA-N 0.000 description 6
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
229940081735 acetylcellulose Drugs 0.000 description 6
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 6
239000002585 base Substances 0.000 description 6
239000001913 cellulose Substances 0.000 description 6
238000002156 mixing Methods 0.000 description 6
208000014837 parasitic helminthiasis infectious disease Diseases 0.000 description 6
230000000717 retained effect Effects 0.000 description 6
230000001225 therapeutic effect Effects 0.000 description 6
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 5
229920002301 cellulose acetate Polymers 0.000 description 5
235000019253 formic acid Nutrition 0.000 description 5
230000006870 function Effects 0.000 description 5
238000005470 impregnation Methods 0.000 description 5
239000011734 sodium Substances 0.000 description 5
229910052708 sodium Inorganic materials 0.000 description 5
239000002904 solvent Substances 0.000 description 5
229920000742 Cotton Polymers 0.000 description 4
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
208000006968 Helminthiasis Diseases 0.000 description 4
241000282414 Homo sapiens Species 0.000 description 4
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
230000000507 anthelmentic effect Effects 0.000 description 4
230000004888 barrier function Effects 0.000 description 4
MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 4
239000012153 distilled water Substances 0.000 description 4
229920001971 elastomer Polymers 0.000 description 4
230000007613 environmental effect Effects 0.000 description 4
239000000499 gel Substances 0.000 description 4
239000007943 implant Substances 0.000 description 4
238000001727 in vivo Methods 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
244000045947 parasite Species 0.000 description 4
239000008363 phosphate buffer Substances 0.000 description 4
239000007787 solid Substances 0.000 description 4
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical group C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 3
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
206010016717 Fistula Diseases 0.000 description 3
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
241000243789 Metastrongyloidea Species 0.000 description 3
239000004743 Polypropylene Substances 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
208000021017 Weight Gain Diseases 0.000 description 3
230000008901 benefit Effects 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
229920001577 copolymer Polymers 0.000 description 3
229910052802 copper Inorganic materials 0.000 description 3
239000010949 copper Substances 0.000 description 3
239000003937 drug carrier Substances 0.000 description 3
238000012377 drug delivery Methods 0.000 description 3
238000011067 equilibration Methods 0.000 description 3
210000003608 fece Anatomy 0.000 description 3
239000000835 fiber Substances 0.000 description 3
230000003890 fistula Effects 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
150000002500 ions Chemical class 0.000 description 3
230000014759 maintenance of location Effects 0.000 description 3
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
229910052753 mercury Inorganic materials 0.000 description 3
239000012229 microporous material Substances 0.000 description 3
229920001223 polyethylene glycol Polymers 0.000 description 3
229920002635 polyurethane Polymers 0.000 description 3
239000004814 polyurethane Substances 0.000 description 3
229920002689 polyvinyl acetate Polymers 0.000 description 3
239000011118 polyvinyl acetate Substances 0.000 description 3
230000000069 prophylactic effect Effects 0.000 description 3
230000009467 reduction Effects 0.000 description 3
235000019333 sodium laurylsulphate Nutrition 0.000 description 3
239000000600 sorbitol Substances 0.000 description 3
229920001059 synthetic polymer Polymers 0.000 description 3
235000019786 weight gain Nutrition 0.000 description 3
230000004584 weight gain Effects 0.000 description 3
SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 2
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
229920002972 Acrylic fiber Polymers 0.000 description 2
241000251468 Actinopterygii Species 0.000 description 2
229920000936 Agarose Polymers 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
108010001478 Bacitracin Proteins 0.000 description 2
FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 2
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
239000005977 Ethylene Substances 0.000 description 2
241000282412 Homo Species 0.000 description 2
WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
229910001209 Low-carbon steel Inorganic materials 0.000 description 2
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
229930193140 Neomycin Natural products 0.000 description 2
239000004677 Nylon Substances 0.000 description 2
206010067720 Parasitic gastroenteritis Diseases 0.000 description 2
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
208000035415 Reinfection Diseases 0.000 description 2
KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
229960000723 ampicillin Drugs 0.000 description 2
230000000844 anti-bacterial effect Effects 0.000 description 2
229960003071 bacitracin Drugs 0.000 description 2
229930184125 bacitracin Natural products 0.000 description 2
CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 2
229940088623 biologically active substance Drugs 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
239000010839 body fluid Substances 0.000 description 2
239000002775 capsule Substances 0.000 description 2
239000000969 carrier Substances 0.000 description 2
239000000919 ceramic Substances 0.000 description 2
125000001309 chloro group Chemical group Cl* 0.000 description 2
YOCUPQPZWBBYIX-UHFFFAOYSA-N copper nickel Chemical compound [Ni].[Cu] YOCUPQPZWBBYIX-UHFFFAOYSA-N 0.000 description 2
230000006378 damage Effects 0.000 description 2
230000007423 decrease Effects 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
125000005442 diisocyanate group Chemical group 0.000 description 2
229960003722 doxycycline Drugs 0.000 description 2
238000011049 filling Methods 0.000 description 2
239000012458 free base Substances 0.000 description 2
239000008240 homogeneous mixture Substances 0.000 description 2
238000002513 implantation Methods 0.000 description 2
230000001965 increasing effect Effects 0.000 description 2
239000007791 liquid phase Substances 0.000 description 2
238000011068 loading method Methods 0.000 description 2
210000004072 lung Anatomy 0.000 description 2
239000011777 magnesium Substances 0.000 description 2
229910052749 magnesium Inorganic materials 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
150000002734 metacrylic acid derivatives Chemical class 0.000 description 2
150000002739 metals Chemical class 0.000 description 2
FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 2
229960004927 neomycin Drugs 0.000 description 2
229920001778 nylon Polymers 0.000 description 2
230000037361 pathway Effects 0.000 description 2
239000008188 pellet Substances 0.000 description 2
229940056360 penicillin g Drugs 0.000 description 2
239000012071 phase Substances 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
239000004033 plastic Substances 0.000 description 2
229960005278 poloxalene Drugs 0.000 description 2
229920002401 polyacrylamide Polymers 0.000 description 2
229920005862 polyol Polymers 0.000 description 2
150000003077 polyols Chemical class 0.000 description 2
244000144977 poultry Species 0.000 description 2
239000000047 product Substances 0.000 description 2
GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
210000004767 rumen Anatomy 0.000 description 2
230000001932 seasonal effect Effects 0.000 description 2
238000001179 sorption measurement Methods 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
239000000725 suspension Substances 0.000 description 2
DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
229960000344 thiamine hydrochloride Drugs 0.000 description 2
235000019190 thiamine hydrochloride Nutrition 0.000 description 2
239000011747 thiamine hydrochloride Substances 0.000 description 2
ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 2
229920002554 vinyl polymer Polymers 0.000 description 2
VWRCYAZJKNPEQR-NIEARKAZSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;1-methyl-2-[(e)-2-thiophen-2-ylethenyl]-5,6-dihydro-4h-pyrimidine Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.CN1CCCN=C1\C=C\C1=CC=CS1 VWRCYAZJKNPEQR-NIEARKAZSA-N 0.000 description 1
GRRNUXAQVGOGFE-KPBUCVLVSA-N (3'r,3as,4s,4'r,5'r,6r,6'r,7s,7as)-4-[(1r,2s,3r,5s,6r)-3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy-6'-[(1s)-1-amino-2-hydroxyethyl]-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3ah-[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetrol Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2OC3([C@@H]([C@H](O)[C@@H](O)[C@@H]([C@@H](N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-KPBUCVLVSA-N 0.000 description 1
BXBSPTIDIMGJNO-YZPBMOCRSA-N (3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;hydro Chemical compound Cl.O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 BXBSPTIDIMGJNO-YZPBMOCRSA-N 0.000 description 1
CWYHZGJSHPPEHY-UOBLTHIJSA-N (3r,5s,6s,7r,8s,9r,12r,13r,14s,15r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-8-[(2r,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-1,11-dioxaspiro[2.13]hexadecane-10,16-dione;hydrochlorid Chemical compound Cl.O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](O)[C@@H](C)C(=O)[C@@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C CWYHZGJSHPPEHY-UOBLTHIJSA-N 0.000 description 1
229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
BQCIDUSAKPWEOX-UHFFFAOYSA-N 1,1-Difluoroethene Chemical compound FC(F)=C BQCIDUSAKPWEOX-UHFFFAOYSA-N 0.000 description 1
ZYCUDGIOGBIKAV-IPZCTEOASA-N 1-methyl-2-[(e)-2-thiophen-2-ylethenyl]-5,6-dihydro-4h-pyrimidine;hydrochloride Chemical compound Cl.CN1CCCN=C1\C=C\C1=CC=CS1 ZYCUDGIOGBIKAV-IPZCTEOASA-N 0.000 description 1
ZFHPTBIOMNJVSH-UHFFFAOYSA-N 2,3-dihydroxypropyl dodecyl sulfate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)OCC(O)CO ZFHPTBIOMNJVSH-UHFFFAOYSA-N 0.000 description 1
WCVOGSZTONGSQY-UHFFFAOYSA-N 2,4,6-trichloroanisole Chemical compound COC1=C(Cl)C=C(Cl)C=C1Cl WCVOGSZTONGSQY-UHFFFAOYSA-N 0.000 description 1
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
XKZQKPRCPNGNFR-UHFFFAOYSA-N 2-(3-hydroxyphenyl)phenol Chemical class OC1=CC=CC(C=2C(=CC=CC=2)O)=C1 XKZQKPRCPNGNFR-UHFFFAOYSA-N 0.000 description 1
OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
QVTWQIWXCYMFQI-CZDSEFAFSA-N 2-[(1r,2r,3s,4r,5r,6s)-3-(diaminomethylideneamino)-4-[(2r,3r,4r,5s)-3-[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;trihydrochloride Chemical compound Cl.Cl.Cl.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QVTWQIWXCYMFQI-CZDSEFAFSA-N 0.000 description 1
OLLVTRJWJCUNEY-IAGPQMRQSA-N 2-[(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde hydrochloride Chemical compound Cl.CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(\C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC OLLVTRJWJCUNEY-IAGPQMRQSA-N 0.000 description 1
LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 1
OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
YJGGCARNRYGSPA-IPZCTEOASA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;1-methyl-2-[(e)-2-thiophen-2-ylethenyl]-5,6-dihydro-4h-pyrimidine Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CN1CCCN=C1\C=C\C1=CC=CS1 YJGGCARNRYGSPA-IPZCTEOASA-N 0.000 description 1
VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 1
GWZMWHWAWHPNHN-UHFFFAOYSA-N 2-hydroxypropyl prop-2-enoate Chemical compound CC(O)COC(=O)C=C GWZMWHWAWHPNHN-UHFFFAOYSA-N 0.000 description 1
YQIGLEFUZMIVHU-UHFFFAOYSA-N 2-methyl-n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C(C)=C YQIGLEFUZMIVHU-UHFFFAOYSA-N 0.000 description 1
ZAMLGGRVTAXBHI-UHFFFAOYSA-N 3-(4-bromophenyl)-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)NC(CC(O)=O)C1=CC=C(Br)C=C1 ZAMLGGRVTAXBHI-UHFFFAOYSA-N 0.000 description 1
CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 1
GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 description 1
QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical compound OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 description 1
DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
RREANTFLPGEWEN-MBLPBCRHSA-N 7-[4-[[(3z)-3-[4-amino-5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidin-2-yl]imino-5-fluoro-2-oxoindol-1-yl]methyl]piperazin-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(\N=C/3C4=CC(F)=CC=C4N(CN4CCN(CC4)C=4C(=CC=5C(=O)C(C(O)=O)=CN(C=5C=4)C4CC4)F)C\3=O)=NC=2)N)=C1 RREANTFLPGEWEN-MBLPBCRHSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
229910001369 Brass Inorganic materials 0.000 description 1
NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
241000283707 Capra Species 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
229910000975 Carbon steel Inorganic materials 0.000 description 1
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
241000195493 Cryptophyta Species 0.000 description 1
XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
PGNKBEARDDELNB-UHFFFAOYSA-N Diethylcarbamazine citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCN(CC)C(=O)N1CCN(C)CC1 PGNKBEARDDELNB-UHFFFAOYSA-N 0.000 description 1
101100130497 Drosophila melanogaster Mical gene Proteins 0.000 description 1
229920002466 Dynel Polymers 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
206010061217 Infestation Diseases 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 1
CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
229910000861 Mg alloy Inorganic materials 0.000 description 1
235000002779 Morchella esculenta Nutrition 0.000 description 1
240000002769 Morchella esculenta Species 0.000 description 1
101100345589 Mus musculus Mical1 gene Proteins 0.000 description 1
241000244206 Nematoda Species 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
239000004104 Oleandomycin Substances 0.000 description 1
RZPAKFUAFGMUPI-UHFFFAOYSA-N Oleandomycin Natural products O1C(C)C(O)C(OC)CC1OC1C(C)C(=O)OC(C)C(C)C(O)C(C)C(=O)C2(OC2)CC(C)C(OC2C(C(CC(C)O2)N(C)C)O)C1C RZPAKFUAFGMUPI-UHFFFAOYSA-N 0.000 description 1
239000004100 Oxytetracycline Substances 0.000 description 1
208000030852 Parasitic disease Diseases 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
206010034972 Photosensitivity reaction Diseases 0.000 description 1
108010040201 Polymyxins Proteins 0.000 description 1
239000004721 Polyphenylene oxide Substances 0.000 description 1
229920002396 Polyurea Polymers 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
239000004182 Tylosin Substances 0.000 description 1
229930194936 Tylosin Natural products 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
210000003165 abomasum Anatomy 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
229940022663 acetate Drugs 0.000 description 1
VUEIUPOKAGUERZ-UHFFFAOYSA-N acetic acid formic acid Chemical compound C(C)(=O)O.C(C)(=O)O.C(=O)O.C(C)(=O)O VUEIUPOKAGUERZ-UHFFFAOYSA-N 0.000 description 1
125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
230000002353 algacidal effect Effects 0.000 description 1
150000005215 alkyl ethers Chemical class 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
229910045601 alloy Inorganic materials 0.000 description 1
239000000956 alloy Substances 0.000 description 1
FPQFYIAXQDXNOR-QDKLYSGJSA-N alpha-Zearalenol Chemical compound O=C1O[C@@H](C)CCC[C@H](O)CCC\C=C\C2=CC(O)=CC(O)=C21 FPQFYIAXQDXNOR-QDKLYSGJSA-N 0.000 description 1
229940126575 aminoglycoside Drugs 0.000 description 1
229960003683 amprolium Drugs 0.000 description 1
229910052925 anhydrite Inorganic materials 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000003096 antiparasitic agent Substances 0.000 description 1
229940125687 antiparasitic agent Drugs 0.000 description 1
XZNUGFQTQHRASN-XQENGBIVSA-N apramycin Chemical compound O([C@H]1O[C@@H]2[C@H](O)[C@@H]([C@H](O[C@H]2C[C@H]1N)O[C@@H]1[C@@H]([C@@H](O)[C@H](N)[C@@H](CO)O1)O)NC)[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O XZNUGFQTQHRASN-XQENGBIVSA-N 0.000 description 1
229950006334 apramycin Drugs 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
PERZMHJGZKHNGU-JGYWJTCASA-N bambermycin Chemical compound O([C@H]1[C@H](NC(C)=O)[C@@H](O)[C@@H]([C@H](O1)CO[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1O[C@@H]([C@H]([C@H](O)[C@H]1NC(C)=O)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@H](O1)C(=O)NC=1C(CCC=1O)=O)O)C)[C@H]1[C@@H](OP(O)(=O)OC[C@@H](OC\C=C(/C)CC\C=C\C(C)(C)CCC(=C)C\C=C(/C)CCC=C(C)C)C(O)=O)O[C@H](C(O)=O)[C@@](C)(O)[C@@H]1OC(N)=O PERZMHJGZKHNGU-JGYWJTCASA-N 0.000 description 1
229950007118 bambermycin Drugs 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229940045940 bis(1-methylamyl) sodium sulfosuccinate Drugs 0.000 description 1
230000037396 body weight Effects 0.000 description 1
239000010951 brass Substances 0.000 description 1
239000006189 buccal tablet Substances 0.000 description 1
OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
239000010962 carbon steel Substances 0.000 description 1
238000005266 casting Methods 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
ASOJLQIBBYOFDE-HCHBIZCOSA-N chembl2106443 Chemical compound C(/[C@H]1O[C@H]([C@H]([C@H]1O)O)[C@H](C)[C@H](OC)C(/C)=C/C=C/CNC(=O)[C@@H](CC)[C@]1(O)[C@@H]([C@H](O[C@H]2[C@@H]([C@H](OC)[C@H](O[C@H]3[C@@H]([C@H](O)[C@@H](OC)[C@H](C)O3)OC)[C@@H](C)O2)O)C(C)(C)[C@H](\C=C\C=C\C)O1)O)=C\C=C\C=C(/C)C(=O)C1=C(O)C=CN(C)C1=O ASOJLQIBBYOFDE-HCHBIZCOSA-N 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
239000002131 composite material Substances 0.000 description 1
239000004035 construction material Substances 0.000 description 1
238000011443 conventional therapy Methods 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
239000003431 cross linking reagent Substances 0.000 description 1
230000001955 cumulated effect Effects 0.000 description 1
230000001186 cumulative effect Effects 0.000 description 1
230000001351 cycling effect Effects 0.000 description 1
235000021051 daily weight gain Nutrition 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
239000007933 dermal patch Substances 0.000 description 1
238000011161 development Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
229960003974 diethylcarbamazine Drugs 0.000 description 1
RCKMWOKWVGPNJF-UHFFFAOYSA-N diethylcarbamazine Chemical compound CCN(CC)C(=O)N1CCN(C)CC1 RCKMWOKWVGPNJF-UHFFFAOYSA-N 0.000 description 1
229960004837 diethylcarbamazine citrate Drugs 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
150000002009 diols Chemical class 0.000 description 1
SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
229940043264 dodecyl sulfate Drugs 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000003651 drinking water Substances 0.000 description 1
235000020188 drinking water Nutrition 0.000 description 1
239000000890 drug combination Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
229950003445 efrotomycin Drugs 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
244000079386 endoparasite Species 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
229960003276 erythromycin Drugs 0.000 description 1
125000005670 ethenylalkyl group Chemical group 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
230000029142 excretion Effects 0.000 description 1
239000003925 fat Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
230000002550 fecal effect Effects 0.000 description 1
239000003337 fertilizer Substances 0.000 description 1
235000019374 flavomycin Nutrition 0.000 description 1
239000012530 fluid Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
239000011953 free-radical catalyst Substances 0.000 description 1
ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
244000144993 groups of animals Species 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
150000003840 hydrochlorides Chemical class 0.000 description 1
POUMFISTNHIPTI-BOMBIWCESA-N hydron;(2s,4r)-n-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;chloride Chemical compound Cl.CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 POUMFISTNHIPTI-BOMBIWCESA-N 0.000 description 1
PJBQYZZKGNOKNJ-UHFFFAOYSA-M hydron;5-[(2-methylpyridin-1-ium-1-yl)methyl]-2-propylpyrimidin-4-amine;dichloride Chemical compound Cl.[Cl-].NC1=NC(CCC)=NC=C1C[N+]1=CC=CC=C1C PJBQYZZKGNOKNJ-UHFFFAOYSA-M 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
229940097277 hygromycin b Drugs 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000001524 infective effect Effects 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
230000000749 insecticidal effect Effects 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
239000012948 isocyanate Substances 0.000 description 1
150000002513 isocyanates Chemical class 0.000 description 1
235000015110 jellies Nutrition 0.000 description 1
OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 1
229960005287 lincomycin Drugs 0.000 description 1
229960001595 lincomycin hydrochloride Drugs 0.000 description 1
239000003120 macrolide antibiotic agent Substances 0.000 description 1
229940041033 macrolides Drugs 0.000 description 1
229940097364 magnesium acetate tetrahydrate Drugs 0.000 description 1
XKPKPGCRSHFTKM-UHFFFAOYSA-L magnesium;diacetate;tetrahydrate Chemical compound O.O.O.O.[Mg+2].CC([O-])=O.CC([O-])=O XKPKPGCRSHFTKM-UHFFFAOYSA-L 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
239000003750 molluscacide Substances 0.000 description 1
230000002013 molluscicidal effect Effects 0.000 description 1
239000000178 monomer Substances 0.000 description 1
BSCJIBOZTKGXQP-UHFFFAOYSA-N n-(2-hydroxyethyl)-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NCCO BSCJIBOZTKGXQP-UHFFFAOYSA-N 0.000 description 1
YPHQUSNPXDGUHL-UHFFFAOYSA-N n-methylprop-2-enamide Chemical compound CNC(=O)C=C YPHQUSNPXDGUHL-UHFFFAOYSA-N 0.000 description 1
WDFKEEALECCKTJ-UHFFFAOYSA-N n-propylprop-2-enamide Chemical compound CCCNC(=O)C=C WDFKEEALECCKTJ-UHFFFAOYSA-N 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
239000003921 oil Substances 0.000 description 1
RZPAKFUAFGMUPI-KGIGTXTPSA-N oleandomycin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](O)[C@@H](C)C(=O)[C@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C RZPAKFUAFGMUPI-KGIGTXTPSA-N 0.000 description 1
235000019367 oleandomycin Nutrition 0.000 description 1
229960002351 oleandomycin Drugs 0.000 description 1
229960000535 oxantel Drugs 0.000 description 1
VRYKTHBAWRESFI-VOTSOKGWSA-N oxantel Chemical compound CN1CCCN=C1\C=C\C1=CC=CC(O)=C1 VRYKTHBAWRESFI-VOTSOKGWSA-N 0.000 description 1
125000005702 oxyalkylene group Chemical group 0.000 description 1
125000006353 oxyethylene group Chemical group 0.000 description 1
229960000625 oxytetracycline Drugs 0.000 description 1
229960004368 oxytetracycline hydrochloride Drugs 0.000 description 1
230000024241 parasitism Effects 0.000 description 1
230000003108 parasitologic effect Effects 0.000 description 1
150000002960 penicillins Chemical class 0.000 description 1
230000000361 pesticidal effect Effects 0.000 description 1
239000000575 pesticide Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
238000005191 phase separation Methods 0.000 description 1
230000036211 photosensitivity Effects 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
229960005141 piperazine Drugs 0.000 description 1
238000009372 pisciculture Methods 0.000 description 1
229920001515 polyalkylene glycol Polymers 0.000 description 1
229920000768 polyamine Polymers 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920000570 polyether Polymers 0.000 description 1
230000000379 polymerizing effect Effects 0.000 description 1
239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
229920005749 polyurethane resin Polymers 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
230000001376 precipitating effect Effects 0.000 description 1
230000002265 prevention Effects 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
239000000376 reactant Substances 0.000 description 1
238000009877 rendering Methods 0.000 description 1
WVYADZUPLLSGPU-UHFFFAOYSA-N salsalate Chemical class OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O WVYADZUPLLSGPU-UHFFFAOYSA-N 0.000 description 1
238000005070 sampling Methods 0.000 description 1
239000012047 saturated solution Substances 0.000 description 1
238000007789 sealing Methods 0.000 description 1
229910052711 selenium Inorganic materials 0.000 description 1
239000011669 selenium Substances 0.000 description 1
238000003307 slaughter Methods 0.000 description 1
210000000813 small intestine Anatomy 0.000 description 1
235000015424 sodium Nutrition 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
235000019832 sodium triphosphate Nutrition 0.000 description 1
QJDJVBIQBWDFNZ-UHFFFAOYSA-M sodium;1,4-di(hexan-2-yloxy)-1,4-dioxobutane-2-sulfonate Chemical compound [Na+].CCCCC(C)OC(=O)CC(S([O-])(=O)=O)C(=O)OC(C)CCCC QJDJVBIQBWDFNZ-UHFFFAOYSA-M 0.000 description 1
238000002336 sorption--desorption measurement Methods 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
238000003860 storage Methods 0.000 description 1
229960005322 streptomycin Drugs 0.000 description 1
239000006190 sub-lingual tablet Substances 0.000 description 1
239000000829 suppository Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
229940040944 tetracyclines Drugs 0.000 description 1
229920005992 thermoplastic resin Polymers 0.000 description 1
238000012546 transfer Methods 0.000 description 1
238000011282 treatment Methods 0.000 description 1
ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 1
WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
235000019375 tylosin Nutrition 0.000 description 1
229960004059 tylosin Drugs 0.000 description 1
238000009489 vacuum treatment Methods 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
238000005406 washing Methods 0.000 description 1
229920003176 water-insoluble polymer Polymers 0.000 description 1
239000001993 wax Substances 0.000 description 1
238000005303 weighing Methods 0.000 description 1
229960002300 zeranol Drugs 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
239000011701 zinc Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0068—Rumen, e.g. rumen bolus

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Nutrition Science (AREA)
Physiology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Detergent Compositions (AREA)
Fodder In General (AREA)
Dairy Products (AREA)
Paper (AREA)
External Artificial Organs (AREA)

CA327,100A 1978-05-08 1979-05-07 Delivery system Expired CA1113395A (en)

Applications Claiming Priority (8)

Application Number	Priority Date	Filing Date	Title
US90407878A	1978-05-08	1978-05-08
US90404978A	1978-05-08	1978-05-08
US904,049		1978-05-08
US014,388		1979-02-22
US06/014,388 US4220153A (en)	1978-05-08	1979-02-22	Controlled release delivery system
US014,387		1979-02-22
US06/014,387 US4220152A (en)	1978-05-08	1979-02-22	Delivery system
US904,078		1986-09-04

Publications (1)

Publication Number	Publication Date
CA1113395A true CA1113395A (en)	1981-12-01

Family

ID=27486383

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA327,100A Expired CA1113395A (en)	1978-05-08	1979-05-07	Delivery system

Country Status (40)

Country	Link
JP (1)	JPS5514080A (es)
AR (1)	AR219795A1 (es)
AT (1)	AT389463B (es)
AU (1)	AU513656B2 (es)
BE (1)	BE876074A (es)
CA (1)	CA1113395A (es)
CH (1)	CH643140A5 (es)
CS (1)	CS236761B2 (es)
DD (2)	DD143504A5 (es)
DE (1)	DE2918522C2 (es)
DK (1)	DK153917C (es)
EG (1)	EG15524A (es)
ES (1)	ES8305583A1 (es)
FI (1)	FI75735C (es)
FR (1)	FR2425242A1 (es)
GB (1)	GB2020181B (es)
GR (1)	GR73637B (es)
HK (1)	HK13384A (es)
HU (1)	HU186995B (es)
IE (1)	IE48751B1 (es)
IL (1)	IL57227A (es)
IN (1)	IN152178B (es)
IT (1)	IT1202924B (es)
KE (1)	KE3367A (es)
LU (1)	LU81233A1 (es)
MA (1)	MA18423A1 (es)
MX (1)	MX5953E (es)
NL (1)	NL179703C (es)
NO (1)	NO147902C (es)
NZ (1)	NZ190386A (es)
PH (1)	PH17566A (es)
PL (1)	PL126835B1 (es)
PT (1)	PT69583A (es)
RO (1)	RO81625B (es)
SE (1)	SE440449B (es)
SG (1)	SG65583G (es)
SU (1)	SU1222186A3 (es)
YU (1)	YU44183B (es)
ZA (1)	ZA792129B (es)
ZM (1)	ZM4079A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8305797D0 (en) *	1983-03-02	1983-04-07	Graham N B	Hydrogel-containing envelopes
GB8328916D0 (en) *	1983-10-28	1983-11-30	Castex Prod	Pharmaceutical pellet
GB8403138D0 (en) *	1984-02-07	1984-03-14	Graham N B	Sustained release of active ingredient
NZ212100A (en) *	1984-06-02	1988-07-28	Castex Prod	Rumen bolus; outer casing sheds in segments
US4666704A (en) *	1985-05-24	1987-05-19	International Minerals & Chemical Corp.	Controlled release delivery system for macromolecules
DE3533369A1 (de) *	1985-09-19	1987-03-19	Alois Prof Dr Med Bloemer	Antibioticahaltiges mittel und seine verwendung als chirurgisches kunststoffmaterial
US4717567A (en) *	1985-11-25	1988-01-05	Eastman Kodak Company	Rumen-stable pellets
US5342624A (en) *	1989-02-16	1994-08-30	British Technology Group Ltd.	Dispensing device
DE4100920A1 (de) *	1991-01-15	1992-07-16	Degussa	Wirkstoffzubereitung zur oralen verabreichung an wiederkaeuer
CA2166074C (en) *	1993-07-02	2005-08-23	Mark B. Lyles	Implantable system for cell growth control
US6479066B1 (en)	1999-12-16	2002-11-12	Rst Implanted Cell Technology, Llc	Device having a microporous membrane lined deformable wall for implanting cell cultures
CN1305953C (zh) *	2005-04-06	2007-03-21	福建师范大学	一种具有驱虫功能的塑料农用薄膜母粒的制备方法
MX2023006678A (es)	2020-12-08	2023-08-22	Ruminant Biotech Corp Ltd	Mejoras en los dispositivos y métodos para suministrar sustancias a los animales.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1693890A (en) *	1922-09-11	1928-12-04	Duclaux Jacques	Ultrafilter membrane
US3279996A (en) *	1962-08-28	1966-10-18	Jr David M Long	Polysiloxane carrier for controlled release of drugs and other agents
US3993073A (en) *	1969-04-01	1976-11-23	Alza Corporation	Novel drug delivery device
US3948262A (en) *	1969-04-01	1976-04-06	Alza Corporation	Novel drug delivery device
US3777015A (en) *	1970-01-19	1973-12-04	Alza Corp	Device for suppressing fertility
BE789524A (fr) *	1971-09-30	1973-01-15	Alza Corp	Dispositif de liberation de medicaments
US3948254A (en) *	1971-11-08	1976-04-06	Alza Corporation	Novel drug delivery device
US3975350A (en) *	1972-08-02	1976-08-17	Princeton Polymer Laboratories, Incorporated	Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles
US3846404A (en) *	1973-05-23	1974-11-05	Moleculon Res Corp	Process of preparing gelled cellulose triacetate products and the products produced thereby
US3961628A (en) *	1974-04-10	1976-06-08	Alza Corporation	Ocular drug dispensing system

1979
- 1979-03-21 IN IN188/DEL/79A patent/IN152178B/en unknown
- 1979-03-26 DK DK122779A patent/DK153917C/da not_active IP Right Cessation
- 1979-05-03 ZA ZA792129A patent/ZA792129B/xx unknown
- 1979-05-03 MA MA18616A patent/MA18423A1/fr unknown
- 1979-05-04 GB GB7915602A patent/GB2020181B/en not_active Expired
- 1979-05-06 CS CS793159A patent/CS236761B2/cs unknown
- 1979-05-07 FI FI791452A patent/FI75735C/fi not_active IP Right Cessation
- 1979-05-07 YU YU1066/79A patent/YU44183B/xx unknown
- 1979-05-07 SE SE7903973A patent/SE440449B/sv not_active IP Right Cessation
- 1979-05-07 LU LU81233A patent/LU81233A1/xx unknown
- 1979-05-07 MX MX797956U patent/MX5953E/es unknown
- 1979-05-07 JP JP5560979A patent/JPS5514080A/ja active Granted
- 1979-05-07 GR GR59048A patent/GR73637B/el unknown
- 1979-05-07 AT AT0339379A patent/AT389463B/de not_active IP Right Cessation
- 1979-05-07 NZ NZ190386A patent/NZ190386A/xx unknown
- 1979-05-07 FR FR7911434A patent/FR2425242A1/fr active Granted
- 1979-05-07 NL NLAANVRAGE7903549,A patent/NL179703C/xx not_active IP Right Cessation
- 1979-05-07 ES ES480320A patent/ES8305583A1/es not_active Expired
- 1979-05-07 BE BE0/195018A patent/BE876074A/xx not_active IP Right Cessation
- 1979-05-07 RO RO97439A patent/RO81625B/ro unknown
- 1979-05-07 PT PT69583A patent/PT69583A/pt unknown
- 1979-05-07 NO NO79791514A patent/NO147902C/no unknown
- 1979-05-07 CH CH426279A patent/CH643140A5/de not_active IP Right Cessation
- 1979-05-07 IL IL57227A patent/IL57227A/xx unknown
- 1979-05-07 AU AU46742/79A patent/AU513656B2/en not_active Expired
- 1979-05-07 HU HU823729A patent/HU186995B/hu unknown
- 1979-05-07 SU SU792761214A patent/SU1222186A3/ru active
- 1979-05-07 IT IT22426/79A patent/IT1202924B/it active
- 1979-05-07 EG EG265/79A patent/EG15524A/xx active
- 1979-05-07 CA CA327,100A patent/CA1113395A/en not_active Expired
- 1979-05-08 DD DD79212725A patent/DD143504A5/de unknown
- 1979-05-08 DE DE2918522A patent/DE2918522C2/de not_active Expired
- 1979-05-08 AR AR276441A patent/AR219795A1/es active
- 1979-05-08 ZM ZM40/79A patent/ZM4079A1/xx unknown
- 1979-05-08 PL PL1979215452A patent/PL126835B1/pl unknown
- 1979-08-08 IE IE891/79A patent/IE48751B1/en not_active IP Right Cessation
1980
- 1980-01-21 PH PH23528A patent/PH17566A/en unknown
- 1980-05-08 DD DD80223101A patent/DD152482A5/de unknown
1983
- 1983-11-02 SG SG65583A patent/SG65583G/en unknown
1984
- 1984-01-13 KE KE3367A patent/KE3367A/xx unknown
- 1984-02-16 HK HK133/84A patent/HK13384A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
NL179703C (nl)	1986-11-03
AU513656B2 (en)	1980-12-11
SG65583G (en)	1985-03-29
ATA339379A (de)	1989-05-15
FR2425242B1 (es)	1984-12-14
SE7903973L (sv)	1979-11-09
DD152482A5 (de)	1981-12-02
FI75735B (fi)	1988-04-29
HU186995B (en)	1985-10-28
NO791514L (no)	1979-11-09
JPS5514080A (en)	1980-01-31
DE2918522C2 (de)	1986-06-19
NO147902C (no)	1983-07-06
FI75735C (fi)	1988-08-08
CS236761B2 (en)	1985-05-15
MX5953E (es)	1984-09-06
PL126835B1 (en)	1983-09-30
NZ190386A (en)	1981-04-24
PT69583A (en)	1979-06-01
CH643140A5 (de)	1984-05-30
DK153917C (da)	1989-02-06
GR73637B (es)	1984-03-26
DE2918522A1 (de)	1979-11-15
PL215452A1 (es)	1980-03-10
ES480320A0 (es)	1983-04-16
AU4674279A (en)	1979-11-29
EG15524A (en)	1987-05-30
DK153917B (da)	1988-09-26
IT1202924B (it)	1989-02-15
ZM4079A1 (en)	1981-02-23
YU106679A (en)	1984-10-31
HK13384A (en)	1984-02-24
IN152178B (es)	1983-11-05
GB2020181A (en)	1979-11-14
SU1222186A3 (ru)	1986-03-30
KE3367A (en)	1984-02-10
JPS6118525B2 (es)	1986-05-13
IT7922426A0 (it)	1979-05-07
NO147902B (no)	1983-03-28
DD143504A5 (de)	1980-08-27
BE876074A (fr)	1979-11-07
SE440449B (sv)	1985-08-05
RO81625B (ro)	1983-04-30
ES8305583A1 (es)	1983-04-16
ZA792129B (en)	1980-05-28
NL179703B (nl)	1986-06-02
PH17566A (en)	1984-10-01
AR219795A1 (es)	1980-09-15
AT389463B (de)	1989-12-11
IE48751B1 (en)	1985-05-15
IL57227A0 (en)	1979-09-30
YU44183B (en)	1990-04-30
DK122779A (da)	1979-11-09
NL7903549A (nl)	1979-11-12
IL57227A (en)	1982-04-30
FI791452A (fi)	1979-11-09
FR2425242A1 (fr)	1979-12-07
GB2020181B (en)	1982-10-27
IE790891L (en)	1979-11-08
MA18423A1 (fr)	1979-12-31
RO81625A (ro)	1983-04-29
LU81233A1 (fr)	1979-12-07

Publication	Publication Date	Title
US4220152A (en)	1980-09-02	Delivery system
US4220153A (en)	1980-09-02	Controlled release delivery system
CA1113395A (en)	1981-12-01	Delivery system
FI111516B (fi)	2003-08-15	Hyödyllisen aineen kontrolloiduksi annostelemiseksi tarkoitettu väline
CA1107197A (en)	1981-08-18	Controlled-release compositions for administration of thereapeutic agents to ruminants
DE69106501T2 (de)	1995-05-11	Osmotisches dosiersystem zur verabreichung von flüssigen arzneimitteln.
CA2007463C (en)	1995-01-17	Dispensing devices powered by hydrogel
CA2059377C (en)	1996-08-27	Manufacture of water-swellable hydrophilic articles and drug delivery devices
US5221278A (en)	1993-06-22	Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
DE60317225T2 (de)	2008-05-29	Minimal nachgiebiger volumen-effizienter kolben für osmotische medikamentenabgabesysteme
US3923939A (en)	1975-12-02	Process for improving release kinetics of a monolithic drug delivery device
JP3301612B2 (ja)	2002-07-15	ローディングドースを含む長期配送デバイス
US5266325A (en)	1993-11-30	Preparation of homogeneous hydrogel copolymers
DE69320056T2 (de)	1998-12-10	Abgabevorrichtung mit eingekapselten hilfsmitteln
US5861166A (en)	1999-01-19	Delivery device providing beneficial agent stability
EA200100694A1 (ru)	2001-12-24	Биосовместимые имплантируемые средства доставки глазного препарата с контролируемым высвобождением и способы их применения
PT100944B (pt)	2000-02-29	Dispositivo para o fornecimento osmotico de farmacos com paredes de materiais hidrofobicos
EP0153070B1 (en)	1991-05-08	Laminate device for controlled and prolonged release of substances to an ambient environment
DE2247949A1 (de)	1973-04-05	Einrichtung zur verabreichung von arneimitteln
DE3626559C2 (de)	1997-05-07	Abgabevorrichtung zur Verabreichung eines Wirkstoffs an Wiederkäuer
IE55990B1 (en)	1991-03-13	Programmed release device and method of use thereof
KR830001661B1 (ko)	1983-08-23	개량된 전달 시스템의 제조방법
Goodwin et al.	1991	Granulomatous inflammation and monstrous giant cells in response to intraperitoneal hormone implants in channel catfish (Ictalurus punctatus)
AU2003228177A1 (en)	2003-12-02	Improvements in delivery technology

Legal Events

Date	Code	Title	Description
1998-12-01	MKEX	Expiry